NCT02191605

Brief Summary

Marijuana is by far the mostly commonly used illicit drug during pregnancy, and prenatal exposure to marijuana can have lasting negative effects. However, current answers to this problem are failing to reach most women who use marijuana while pregnant. This project will develop and begin testing two technology-based, highly practical interventions that could reduce the number of children who are prenatally exposed to marijuana.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 16, 2014

Completed
1.2 years until next milestone

Study Start

First participant enrolled

September 30, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2017

Completed
8 months until next milestone

Results Posted

Study results publicly available

July 3, 2018

Completed
Last Updated

July 3, 2018

Status Verified

June 1, 2018

Enrollment Period

1.6 years

First QC Date

July 14, 2014

Results QC Date

May 1, 2018

Last Update Submit

June 4, 2018

Conditions

Keywords

Computerized Brief Intervention

Outcome Measures

Primary Outcomes (2)

  • Number of Participants Abstinent From Marijuana for the 7 Days Prior to Delivery

    Marijuana use will be measured at the time of delivery of their infant by self-report (TimeLine Follow Back interview - TLFB) and urine analysis. This will represent the number of participants who abstinent (reported no marijuana use and had a negative toxicology urine screen) from marijuana for the 7 days prior to delivery.

    self-reported use during 7 days prior to delivery of their baby

  • Number of Participants Abstinent From Marijuana for the 90 Days Prior to Delivery

    Marijuana use will be measured at the time of delivery of their infant by self-report (TimeLine Follow Back interview - TLFB) and hair toxicology analysis. This will represent the number of participants who were abstinent (reported no marijuana use and had a negative hair toxicology results) from marijuana for the 90 days prior to delivery.

    self-reported use during 90 days prior to delivery of their baby

Study Arms (5)

electronic SBIRT (eSBIRT)

EXPERIMENTAL

Participants in this condition will receive empathic exploration of their thoughts regarding marijuana use, provision of information on possible consequences of marijuana use during pregnancy and potential benefits of changing use (with permission), normed feedback, use of Motivational Interviewing techniques to elicit their own reasons for change, video testimonials modeling successful change, and information on change methods with optional goal setting.

Behavioral: eSBIRT

Tailored texting

EXPERIMENTAL

Participants in this condition will chose the frequency and time of text messages that will continue until childbirth or the participant opts out. The text messages will be a mix of marijuana targeted content (without directly referring to marijuana in a way that implies use by the participant) and general content related to healthy pregnancy; using appropriate humor and tips for community resources. Tailoring will focus on gestational age, self-efficacy, and social support.

Behavioral: Tailored texting

eSBIRT & texting

EXPERIMENTAL

Participants in this arm will receive both the computerized intervention and tailored text messaging intervention as described in the eSBIRT and Tailored texting arms.

Behavioral: eSBIRTBehavioral: Tailored texting

Assessment only

NO INTERVENTION

Participants in the arm will participant in screening and the baseline assessment conducted on the computer only. They will not receive an intervention.

Screening only

NO INTERVENTION

Participants in this arm of the study will only answer the screening questions and will not be asked the baseline assessment or participate in an intervention.

Interventions

eSBIRTBEHAVIORAL

A single 20 minute interactive computer-delivered intervention designed to promote motivation to change prenatal marijuana use, without presuming the participant to be currently using marijuana while pregnant.

eSBIRT & textingelectronic SBIRT (eSBIRT)

Group text messaging software from Trumpia, Inc. will be used to create the tailored text messages that will be sent to participants assigned to this intervention. Text messages will sent after the initial study participation visit until childbirth or participant opts out of receiving them.

Tailored textingeSBIRT & texting

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • to 40 years of age
  • weeks or less gestation
  • intention to carry pregnancy to term
  • self-reported marijuana use in month before pregnancy
  • own a cell phone and willingness to receive text messages
  • gives consent to access medical records for collection of birth outcome data

You may not qualify if:

  • frank cognitive impairment or psychosis
  • not able to communicate in English
  • not planning to deliver at a Detroit Medical Center (DMC) hospital
  • previous or current participant in a study conducted by Dr. Ondersma
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Perinatal Research Branch participant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wayne State University

Detroit, Michigan, 48202, United States

Location

MeSH Terms

Conditions

Marijuana Use

Condition Hierarchy (Ancestors)

BehaviorSubstance-Related DisordersMental Disorders

Results Point of Contact

Title
Dr. Jessica Beatty
Organization
Wayne State University, Merrill Palmer Skillman Institute

Study Officials

  • Steven J Ondersma, PhD

    Wayne State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 14, 2014

First Posted

July 16, 2014

Study Start

September 30, 2015

Primary Completion

April 20, 2017

Study Completion

October 27, 2017

Last Updated

July 3, 2018

Results First Posted

July 3, 2018

Record last verified: 2018-06

Locations